Art Market Integrity Act

Senate Bill

S. 2400

119th Congress

Art Market Integrity Act

In Committee

Introduced:Jul 23, 2025

Primary Sponsor

Edward Markey

D - MA

Cosponsors

0

Quick Stats

Policy Area

Health

Summary

This bill would require the Department of Health and Human Services to create rules to prevent the misuse of man-made gene products. It would make sure that any federal agency or organization that gets federal funding can only buy these products from providers that follow the screening protocols.

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Introduced7/23/2025

StatusRead twice and referred to the Committee on Banking, Housing, and Urban Affairs.

ChamberSenate

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Art Market Integrity Act

This bill would require the Department of Health and Human Services to create rules to prevent the misuse of man-made gene products. It would make sure that any federal agency or organization that gets federal funding can only buy these products from providers

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill would require the Department of Health and Human Services to create rules to prevent the misuse of man-made gene products. It would make sure that any federal agency or organization that gets federal funding can only buy these products from providers that follow the screening protocols.

Bill Number: 2400
Introduced: 7/23/2025
Status: Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: Art Market Integrity Act
Bill Number: 2400
Sponsor: No sponsor
Status: Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Introduced: 7/23/2025
Summary: This bill would require the Department of Health and Human Services to create rules to prevent the misuse of man-made gene products. It would make sure that any federal agency or organization that gets federal funding can only buy these products from providers that follow the screening protocols.

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill would require the Department of Health and Human Services to create rules to prevent the misuse of man-made gene products. It would make sure that any federal agency or organization that gets federal funding can only buy these products from providers that follow the screening protocols.

Last updated: 12/30/2025

Official Summary

Congressional Research Service summary

Securing Gene Synthesis ActThis bill requires the Department of Health and Human Services to issue regulations to prevent the misuse of de novo gene synthesis products (i.e., manufactured gene products), including screening protocols for providers of these products. Federal agencies and entities that receive federal funds may only purchase such products from providers that comply with the screening protocols.

Key Points

Main provisions of the bill

Establishes screening protocols for providers of manufactured gene products to prevent misuse
Requires federal agencies and entities that receive federal funds to only purchase gene products from providers that comply with the screening protocols
Aims to enhance safety and security around synthetic gene technology

How This Impacts Americans

Potential effects on citizens and communities

This bill would impact federal agencies, research institutions, and private companies that work with synthetic genes and gene products. It could increase oversight and regulations around this emerging technology, which could have implications for scientific research, medical applications, and biosecurity.

Policy Areas

Primary Policy Area

Health

Related Subjects

Administrative law and regulatory procedures

Congressional oversight

Department of Health and Human Services

Drug safety, medical device, and laboratory regulation

Genetics

Health technology, devices, supplies

Medical research

Research administration and funding

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

2400, 119th Congress (2025). "Art Market Integrity Act". Source: Voter's Right Platform. https://votersright.org/bills/118-s-2400

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.

Related Bills in Health

HR 3021

Empowering Patient Choice of Medical Care Act

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means

HR 2111

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Referred to the House Committee on Energy and Commerce.

HR 2884

Anti-Racism in Public Health Act of 2025

Referred to the House Committee on Energy and Commerce.

S 1406

SOAR Act of 2025

Read twice and referred to the Committee on Finance.